Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of triptorelin pamoate 11.25 mg in children with precocious puberty
2008-000565-39Phase 3Completed
- Sponsor
- Ipsen
- Start
- Feb 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of triptorelin in precocious puberty, sponsored by Ipsen. Primary endpoint: Proportion of children with stabilization or regression of Tanner stage. Started Feb 2008; status: completed.
02
Drugs
triptorelin
03
Conditions
precocious puberty
Beyond the preview
Go deeper on 2008-000565-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000565-39.